CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Metformin for the Prevention of the Metabolic Side-effects of Zyprexa [Phase 4]
Summary
Phase 4 trial evaluating metformin to prevent metabolic side-effects of Zyprexa has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rush University Medical Center | Conditions: Metabolic Complications | Phase 4 | Status: COMPLETED | Results posted: 2021-02-02